mebendazole has been researched along with Schistosoma haematobia Infection in 3 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dona López, MC | 1 |
Ramirez Fernández, E | 1 |
Vázquez González, MT | 1 |
Pérez Caloto, M | 1 |
Al-Waili, NS | 2 |
1 trial available for mebendazole and Schistosoma haematobia Infection
Article | Year |
---|---|
[The use of mebendazole associated with inoxuprin in the treatment of Schistosomiasis haematobium].
Topics: Adjuvants, Immunologic; Adolescent; Animals; Antinematodal Agents; Child; Drug Therapy, Combination; | 1998 |
2 other studies available for mebendazole and Schistosoma haematobia Infection
Article | Year |
---|---|
Mebendazole in the treatment of Schistosoma haematobium.
Topics: Adult; Humans; Male; Mebendazole; Schistosomiasis haematobia | 1987 |
Effects of mebendazole on patients infected with Schistosoma mansoni and S. haematobium: preliminary study.
Topics: Adult; Child; Humans; Mebendazole; Schistosomiasis haematobia; Schistosomiasis mansoni | 1988 |